target audience: TECH BUYER Publication date: Dec 2022 - Document type: IDC MarketScape - Doc Document number: # US48061622
IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment
This IDC study focuses on a combination of PV technology solutions and consulting services. This IDC MarketScape provides a qualitative and quantitative assessment based on criteria that should be important to life science companies when considering the selection of a strategic PV solution provider to help provide guidance for strategic, operational, and tactical transformation issues within the PV space, as well as technology platforms, and build capabilities. This is the second time that an IDC MarketScape assessment of PV solutions for life science R&D has been performed.
Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology at IDC, noted, "Pharmacovigilance has gained significant importance and a more visible public profile post the COVID-19 pandemic. The surge in the volume of cases, the need to accelerate innovation while ensuring patient safety, and the need to address the distrust that the pharma industry experienced during the pandemic, all call for a focused effort toward implementing a forward-looking PV strategy and adopting technology solutions that leverage cognitive automation, build compliance, drive efficiency, ensure patient safety, and build transparency and trust."